Role of silent polymorphisms within the dopamine D1 receptor associated with schizophrenia on D1-D2 receptor hetero-dimerization. 2009

Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
Department of Physical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, PL 30-387 Kraków, Poland.

Within the coding region of the dopamine D(1) receptor (D(1)R), two synonymous polymorphisms, D(1)R(G198A) and D(1)R(G1263), have been identified and postulated to correlate with the schizophrenia phenotype. Binding studies revealed that the density of these genetic variants was much lower than the density of wild type D(1)R in the human embryonic kidney (HEK) 293 cell line, used as a model system. From the data obtained using MFOLD software it is apparent that the G198A mutation has a greater impact on the secondary structure of the mRNA, which may affect its translation. However, the G1263A mutation is localized within the serine 421 codon of D(1)R, which is predicted to be a potential site of phosphorylation according to the PHOSIDA database. In order to determine whether the studied synonymous polymorphisms influence the process of dopamine D(1)-D(2) receptors heterodimerization, we employed fluorescence resonance energy transfer (FRET) technology. The dopamine D(2) receptor (D(2)R) was tagged with cyan fluorescence protein and the D(1)R and its genetic variants were tagged with yellow fluorescence protein. The degree of D(1)-D(2) receptor hetero-dimerization was significantly decreased when genetic variants of D(1)R were co-expressed with D(2)R. Since the D(1)R mutations affected the expression levels of the proteins in the cell membrane without affecting the cellular localization of the receptor proteins, we postulated that the D(1)R polymorphisms altered the translation rate and protein structure of the receptor. The altered hetero-dimerization that likely results from the lower expression of these genetic variants of D(1)R with D(2)R may be partially responsible for the association of both G198A and G1263A polymorphisms with the schizophrenia phenotype.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005456 Fluorescent Dyes Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. Flourescent Agent,Fluorescent Dye,Fluorescent Probe,Fluorescent Probes,Fluorochrome,Fluorochromes,Fluorogenic Substrates,Fluorescence Agents,Fluorescent Agents,Fluorogenic Substrate,Agents, Fluorescence,Agents, Fluorescent,Dyes, Fluorescent,Probes, Fluorescent,Substrates, Fluorogenic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012984 Software Sequential operating programs and data which instruct the functioning of a digital computer. Computer Programs,Computer Software,Open Source Software,Software Engineering,Software Tools,Computer Applications Software,Computer Programs and Programming,Computer Software Applications,Application, Computer Software,Applications Software, Computer,Applications Softwares, Computer,Applications, Computer Software,Computer Applications Softwares,Computer Program,Computer Software Application,Engineering, Software,Open Source Softwares,Program, Computer,Programs, Computer,Software Application, Computer,Software Applications, Computer,Software Tool,Software, Computer,Software, Computer Applications,Software, Open Source,Softwares, Computer Applications,Softwares, Open Source,Source Software, Open,Source Softwares, Open,Tool, Software,Tools, Software
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic

Related Publications

Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
September 2008, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
January 2008, Pharmacological reports : PR,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
April 2009, Molecular pharmacology,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
June 1991, The Japanese journal of psychiatry and neurology,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
March 2010, Poultry science,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
April 2017, Pharmacological reports : PR,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
February 1993, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
August 2007, Molecular pharmacology,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
January 1989, Psychopharmacology series,
Katarzyna Grymek, and Sylwia Łukasiewicz, and Agata Faron-Góreckaa, and Magdalena Tworzydlo, and Agnieszka Polit, and Marta Dziedzicka-Wasylewska
November 2015, Molecular psychiatry,
Copied contents to your clipboard!